1 |
0.12% saline |
- |
- |
- |
- |
299 1件: 299 💬 |
2 |
0.9% isotonic saline (is) |
- |
- |
- |
- |
299 1件: 299 💬 |
3 |
0.9% isotonic saline (is), 4ml |
- |
- |
- |
- |
299 1件: 299 💬 |
4 |
0.9% normal saline (control) |
- |
- |
- |
- |
299 1件: 299 💬 |
5 |
0.9% physiological saline |
- |
- |
- |
- |
266 1件: 266 💬 |
6 |
0.9% saline |
- |
- |
- |
- |
070 1件: 70 💬 |
7 |
0.9% sodium chloride (normal saline) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 1件: 6 💬 |
8 |
2-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[e]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1h-benz[e]-indolium hydroxide,inner salt |
Hydroxide ion |
- |
- |
- |
046 1件: 46 💬 |
9 |
3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(n-butyloxylcarbamate)-sulphonamide] sodium salt |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
10 |
5-amino salicylic acid |
Salicylic acid |
1件: D00097 D00097 💬 |
- |
- |
097 1件: 97 💬 |
11 |
5-amino salicylic acid (5-asa) |
Mesalazine |
2件: D00097 D00097, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
12 |
6% hypertonic saline (hs), 4ml |
- |
- |
- |
- |
299 1件: 299 💬 |
13 |
7% hypertonic saline (hs) |
- |
- |
- |
- |
299 1件: 299 💬 |
14 |
7% saline |
- |
- |
- |
- |
299 1件: 299 💬 |
15 |
[tolvaptan 15] |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
16 |
[tolvaptan 30] |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
17 |
[tolvaptan 45/15] |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
18 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
113 1件: 113 💬 |
19 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
20 |
Acetazolamide sandoz 250 |
Acetazolamide |
2件: D00218 D00218, D01196 D01196 💬 |
CA1 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion 7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
225 1件: 225 💬 |
21 |
Active treatment group 7% hypertonic saline |
- |
- |
- |
- |
299 1件: 299 💬 |
22 |
Alirocumab sar236553 (regn727) |
Alirocumab |
1件: D10335 D10335 💬 |
PCSK9 1件: PCSK9 💬 |
Cholesterol metabolism 1件: Cholesterol metabolism |
079 1件: 79 💬 |
23 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
24 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
6件: D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 3件: OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 1件: 78 💬 |
25 |
Amorphous calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
235 1件: 235 💬 |
26 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
27 |
Arthroscopy & saline irrigation alone |
- |
- |
- |
- |
046 1件: 46 💬 |
28 |
Artificial saliva |
- |
- |
- |
- |
053 1件: 53 💬 |
29 |
Atg+cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
30 |
Atg+rapamune+cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
31 |
Behavioral: increased dietary intake of salmon or cod |
Salmon, unspecified |
- |
- |
- |
097 1件: 97 💬 |
32 |
Benazepril |
Benazepril |
2件: D00620 D00620, D07499 D07499 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 4件: 49, 57, 218, 224 💬 |
33 |
Benazepril hydrochloride tablets |
Benazepril |
2件: D00620 D00620, D07499 D07499 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
224 1件: 224 💬 |
34 |
Benazepril pill |
Benazepril |
2件: D00620 D00620, D07499 D07499 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 1件: 49 💬 |
35 |
Benazepril, valsartan and fluvastatin |
Benazepril |
5件: D00400 D00400, D00620 D00620, D00892 D00892, D07499 D07499, D07983 D07983 💬 |
ACE 3件: ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
218 1件: 218 💬 |
36 |
Biological sampling |
- |
- |
- |
- |
065 1件: 65 💬 |
37 |
Biological samplings |
- |
- |
- |
- |
096 1件: 96 💬 |
38 |
Biopsy of the labial salivary gland |
- |
- |
- |
- |
053 1件: 53 💬 |
39 |
Blood and stools samples |
- |
- |
- |
- |
096 1件: 96 💬 |
40 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
41 |
Blood sample and environmental survey |
- |
- |
- |
- |
002 1件: 2 💬 |
42 |
Blood sample collection |
- |
- |
- |
- |
085 1件: 85 💬 |
43 |
Blood samples |
- |
- |
- |
- |
013 8件: 13, 41, 46, 51, 61, 97, 227, 271 💬 |
44 |
Blood sampling |
- |
- |
- |
- |
013 5件: 13, 17, 19, 51, 96 💬 |
45 |
Bnp blood sample test |
- |
- |
- |
- |
058 1件: 58 💬 |
46 |
Bortezomib/dexamethasone |
Bortezomib |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 2件: NR3C1, PSMB5 💬 |
Alzheimer disease 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
283 1件: 283 💬 |
47 |
Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone |
Bortezomib |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 2件: NR3C1, PSMB5 💬 |
Alzheimer disease 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 1件: 28 💬 |
48 |
Botox 200u in normal saline |
- |
- |
- |
- |
226 1件: 226 💬 |
49 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
14件: D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
50 |
Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine. |
Busulfan |
6件: D00184 D00184, D00248 D00248, D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
PPP3CA 6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 2件: 60, 285 💬 |
51 |
Calcitonin (salmon) |
Salmon, unspecified |
- |
- |
- |
225 1件: 225 💬 |
52 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 2件: 96, 97 💬 |
53 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
54 |
Calcium carbonate and alphacalcidol |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
235 1件: 235 💬 |
55 |
Calcium carbonate d |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
053 1件: 53 💬 |
56 |
Cannabis based medicine extract (sativex) |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
57 |
Cannabis sativa extract oromucosal spray |
Medical Cannabis |
- |
- |
- |
002 1件: 2 💬 |
58 |
Cas # in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 1件: 254 💬 |
59 |
Cas# in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 1件: 254 💬 |
60 |
Cevimeline |
Cevimeline |
2件: D00661 D00661, D07667 D07667 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
053 1件: 53 💬 |
61 |
Chf6333 (part 1 - sad) |
- |
- |
- |
- |
299 1件: 299 💬 |
62 |
Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine |
Azathioprine |
12件: D00238 D00238, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994, D03033 D03033 💬 |
MS4A1 2件: MS4A1, NR3C1 💬 |
Hematopoietic cell lineage 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
035 1件: 35 💬 |
63 |
Combination therapy with vigabatrin and prednisolone |
Prednisolone |
9件: D00472 D00472, D00535 D00535, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
ABAT 2件: ABAT, NR3C1 💬 |
Alanine, aspartate and glutamate metabolism 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 1件: 145 💬 |
64 |
Control group 0.9% isotonic saline |
- |
- |
- |
- |
299 1件: 299 💬 |
65 |
Control intervention (no dexamethasone) |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
66 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
21件: D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
67 |
Cosyntropin injectable suspension 1 mg/ml + vigabatrin |
Tetracosactide |
2件: D00284 D00284, D00535 D00535 💬 |
ABAT 2件: ABAT, MC2R 💬 |
Alanine, aspartate and glutamate metabolism 12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway |
145 1件: 145 💬 |
68 |
Culture of lymphoblastoid line from blood sample |
- |
- |
- |
- |
102 1件: 102 💬 |
69 |
Cyclophosphamide, bortezomib, and dexamethasone (cybord) |
Bortezomib |
12件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 2件: NR3C1, PSMB5 💬 |
Alzheimer disease 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 1件: 28 💬 |
70 |
Cyclophosphamide, bortezomib, dexamethasone |
Bortezomib |
12件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 2件: NR3C1, PSMB5 💬 |
Alzheimer disease 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 1件: 28 💬 |
71 |
Cyclophosphamide, bortezomib, dexamethasone plus daratumumab |
Bortezomib |
13件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760, D10777 D10777 💬 |
CD38 3件: CD38, NR3C1, PSMB5 💬 |
Alzheimer disease 16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia |
028 1件: 28 💬 |
72 |
Cyclophosphamide,cyclosporine a |
Cyclophosphamide |
3件: D00184 D00184, D00287 D00287, D07760 D07760 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
73 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
74 |
Cyclosporine (gengraf ) |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
75 |
Cyclosporine (usan) |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 1件: 97 💬 |
76 |
Cyclosporine 5 mg/kg bid days 0-14 |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 2件: 38, 39 💬 |
77 |
Cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 10件: 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
78 |
Cyclosporine a (csa) |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 2件: 19, 60 💬 |
79 |
Cyclosporine a dry powder inhalation (drug) |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
80 |
Cyclosporine combine with mycophenolate mofetil |
Cyclosporine |
5件: D00184 D00184, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 7件: IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 35件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
283 1件: 283 💬 |
81 |
Cyclosporine inhalation solution |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
82 |
Cyclosporine inhalation solution (cis) |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
83 |
Cyclosporine oral product |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
84 |
Cyclosporine pill |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
056 1件: 56 💬 |
85 |
Cyclosporine vs infliximab |
Cyclosporine |
2件: D00184 D00184, D02598 D02598 💬 |
PPP3CA 6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway |
097 1件: 97 💬 |
86 |
Cyclosporine-a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
095 1件: 95 💬 |
87 |
Device: 30-hour ambulatory sampling of intestinal fluid |
- |
- |
- |
- |
083 1件: 83 💬 |
88 |
Device: cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 2件: 19, 20 💬 |
89 |
Device: dexamethasone injection |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
090 1件: 90 💬 |
90 |
Device: frequently sampled oral glucose tolerance test and cgm |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
91 |
Device: oxygen saturation |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
084 1件: 84 💬 |
92 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
93 |
Dexamethasone (1 cycle) |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
94 |
Dexamethasone (4 cycles) |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
95 |
Dexamethasone (50mg 1dd6, 3 consecutive days/month) |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 1件: 35 💬 |
96 |
Dexamethasone 0,1 mg tablets |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
97 |
Dexamethasone 0,5mg |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
98 |
Dexamethasone 0.5mg tablet |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
99 |
Dexamethasone 0.5mg/5ml solution |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 2件: 35, 162 💬 |
100 |
Dexamethasone 0.5mg/5ml solution in mucolox™ |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 2件: 35, 162 💬 |
101 |
Dexamethasone 1,5 mg tablets |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
102 |
Dexamethasone 21-dihydrogen phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
065 1件: 65 💬 |
103 |
Dexamethasone 21-phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
104 |
Dexamethasone 2mg tablets |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
105 |
Dexamethasone 4 mg jenapharm |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
028 1件: 28 💬 |
106 |
Dexamethasone abcur |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
107 |
Dexamethasone and rituximab |
Dexamethasone |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994 💬 |
MS4A1 2件: MS4A1, NR3C1 💬 |
Hematopoietic cell lineage 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
108 |
Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
235 1件: 235 💬 |
109 |
Dexamethasone parotid irrigation |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
053 1件: 53 💬 |
110 |
Dexamethasone sodium phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
065 3件: 65, 70, 96 💬 |
111 |
Dexamethasone sodium phosphate 250 mg/ 10 ml |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
112 |
Dexamethasone sodium phosphate 250 mg/10 ml solution |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
299 1件: 299 💬 |
113 |
Dexamethasone sodium phosphate ph. eur. |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
065 1件: 65 💬 |
114 |
Dexamethasone sodium sulfate |
Dexamethasone |
11件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01732 D01732, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D05877 D05877 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
028 1件: 28 💬 |
115 |
Dexamethasone soduim phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
116 |
Dexamethasone, 40 mg |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
028 1件: 28 💬 |
117 |
Dextran sodium sulfur salt 5, mw 5 kda. a type of low molecular weight dextran sulfate (lmw-ds) |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 1件: 2 💬 |
118 |
Diagnostic test: auto-assessment manikins (sam) |
- |
- |
- |
- |
006 1件: 6 💬 |
119 |
Diagnostic test: blood sample , doppler of uterine vessel and placenta |
- |
- |
- |
- |
288 1件: 288 💬 |
120 |
Diagnostic test: dexamethasone test |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
121 |
Diagnostic test: iontophoresis sessions in forearm of subjects with pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 1件: 299 💬 |
122 |
Diagnostic test: saliva swab |
- |
- |
- |
- |
075 1件: 75 💬 |
123 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
124 |
Diphenhydramine hydrochloride |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 1件: 11 💬 |
125 |
Dipotassium salt |
- |
- |
- |
- |
046 1件: 46 💬 |
126 |
Donepezil sandoz |
Donepezil |
2件: D00670 D00670, D07869 D07869 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
006 1件: 6 💬 |
127 |
Dried blood spot (dbs) sampling |
- |
- |
- |
- |
019 1件: 19 💬 |
128 |
Drug: salirumab |
- |
- |
- |
- |
046 1件: 46 💬 |
129 |
Edoxaban |
Edoxaban |
2件: D09546 D09546, D09710 D09710 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 2件: 46, 88 💬 |
130 |
Erythromycin |
Erythromycin |
9件: D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
006 5件: 6 , 36, 164, 228, 291 💬 |
131 |
Etanercepet, rituximab, abatacept, tocilizumab, sarilumab |
Abatacept |
4件: D02596 D02596, D02994 D02994, D03203 D03203, D10161 D10161 💬 |
CD80 4件: CD80, CD86, IL6R, MS4A1 💬 |
Allograft rejection 24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
132 |
Extra blood draw samples |
- |
- |
- |
- |
300 1件: 300 💬 |
133 |
Faecal sampling |
- |
- |
- |
- |
046 1件: 46 💬 |
134 |
Flucloxacillin |
Flucloxacillin |
3件: D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 1件: 299 💬 |
135 |
Flucloxacillin 250mg/5ml sugar-free powder for oral solution |
Flucloxacillin |
3件: D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 1件: 299 💬 |
136 |
Flucloxacillin sodium |
Flucloxacillin |
3件: D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 1件: 299 💬 |
137 |
Fluoxetine |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 4件: 13, 17, 78, 86 💬 |
138 |
Fluoxetine hydrochloride |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 1件: 13 💬 |
139 |
Forlax 4 g, poudre pour solution buvable en sachet |
- |
- |
- |
- |
299 1件: 299 💬 |
140 |
Gallium-68-dota-n-octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 1件: 84 💬 |
141 |
Genetic: blood or saliva sample collection |
- |
- |
- |
- |
299 1件: 299 💬 |
142 |
Glycerol/saline |
Glycerin |
1件: D00028 D00028 💬 |
- |
- |
316 2件: 316, 317 💬 |
143 |
Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim) |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 1件: 229 💬 |
144 |
Gm-csf [leukine (sargramostim)] |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 1件: 229 💬 |
145 |
Green tea leaf |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
017 1件: 17 💬 |
146 |
Gsk1265744b (sodium salt) containing 14c-gsk1265744b |
- |
- |
- |
- |
265 1件: 265 💬 |
147 |
Gz/sar402671 |
- |
- |
- |
- |
006 2件: 6 , 19 💬 |
148 |
Gz402671 / sar402671 |
- |
- |
- |
- |
019 1件: 19 💬 |
149 |
Herbal treatment (sa100) |
- |
- |
- |
- |
097 1件: 97 💬 |
150 |
High dose dexamethasone pulses |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
151 |
Hypertonic saline |
- |
- |
- |
- |
299 1件: 299 💬 |
152 |
Hypertonic saline (7 %) and isotonic saline (0.9%) |
- |
- |
- |
- |
299 1件: 299 💬 |
153 |
Hypertonic saline (7%) |
- |
- |
- |
- |
299 1件: 299 💬 |
154 |
Hypertonic saline 6% - |
- |
- |
- |
- |
299 1件: 299 💬 |
155 |
Hypertonic saline 7% |
- |
- |
- |
- |
299 1件: 299 💬 |
156 |
Hypertonic saline solution |
- |
- |
- |
- |
299 1件: 299 💬 |
157 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
158 |
Iloprost sale di trometamolo |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
159 |
Incb028050 phosphate salt |
Phosphate ion |
- |
- |
- |
046 1件: 46 💬 |
160 |
Inhaled 7% hypertonic saline (hs) |
- |
- |
- |
- |
299 1件: 299 💬 |
161 |
Inhaled hypertonic saline (7%) |
- |
- |
- |
- |
299 1件: 299 💬 |
162 |
Injection of normal saline |
- |
- |
- |
- |
006 1件: 6 💬 |
163 |
Intraarticular dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
164 |
Intravenous dexamethasone 1 mg |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
165 |
Iron sucrose |
Iron sucrose |
2件: D00025 D00025, D04616 D04616 💬 |
- |
- |
062 3件: 62, 96, 97 💬 |
166 |
Isatuximab |
Isatuximab |
1件: D11050 D11050 💬 |
CD38 1件: CD38 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
028 2件: 28, 61 💬 |
167 |
Isatuximab sar650984 |
Isatuximab |
1件: D11050 D11050 💬 |
CD38 1件: CD38 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
061 1件: 61 💬 |
168 |
Isotonic saline |
- |
- |
- |
- |
299 1件: 299 💬 |
169 |
Isotonic saline 0.9% |
- |
- |
- |
- |
299 1件: 299 💬 |
170 |
Jinarc - tolvaptan tablets |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
171 |
Kuvan® (sapropterin dihydrochloride) |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
172 |
Lactobacillus salivarius ucc118 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
173 |
Lademirsen (sar339375) |
- |
- |
- |
- |
218 1件: 218 💬 |
174 |
Leflunomide-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
3件: D00448 D00448, D00749 D00749, D08050 D08050 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
046 1件: 46 💬 |
175 |
Lenalidomide and dexamethasone |
Dexamethasone |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 1件: 16 💬 |
176 |
Lenalidomide+dexamethasone |
Dexamethasone |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 1件: 16 💬 |
177 |
Lenalidomide, dexamethasone |
Dexamethasone |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 1件: 16 💬 |
178 |
Lenalidomide, dexamethasone and cyclophosphamide |
Cyclophosphamide |
12件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687, D07760 D07760 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 1件: 28 💬 |
179 |
Leucovorin |
Leucovorin |
3件: D01211 D01211, D07986 D07986, D07987 D07987 💬 |
- |
- |
019 2件: 19, 46 💬 |
180 |
Lingzhi and sen miao san |
- |
- |
- |
- |
046 1件: 46 💬 |
181 |
Liposomal aerosol cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
182 |
Liposomal cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
183 |
Liposomal cyclosporine a 10 mg |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
184 |
Liposomal cyclosporine a 5 mg |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
185 |
Liraglutide |
Liraglutide |
1件: D06404 D06404 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 3件: 6 , 75, 193 💬 |
186 |
Long term follow up in all patients who received sar422459 in previous study tdu13583 |
- |
- |
- |
- |
301 1件: 301 💬 |
187 |
Lys-saf302 |
- |
- |
- |
- |
019 1件: 19 💬 |
188 |
Me2125 (safinamide mesilate) |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
189 |
Melphalan, thalidomide and dexamethasone |
Dexamethasone |
11件: D00292 D00292, D00369 D00369, D00754 D00754, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 1件: 28 💬 |
190 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
191 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
192 |
Metformine sandoz 850 mg filmomhulde tabletten |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
081 1件: 81 💬 |
193 |
Methotrexate + salazopyrine + hydroxychloroquine administration |
Hydroxychloroquine |
3件: D00142 D00142, D02115 D02115, D08050 D08050 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
194 |
Methotrexate plus sulfasalazine |
Methotrexate |
3件: D00142 D00142, D00448 D00448, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
195 |
Methotrexate, leucovorin and bms-986142 |
BMS-986142 |
5件: D00142 D00142, D01211 D01211, D02115 D02115, D07986 D07986, D07987 D07987 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
196 |
Methotrexate-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
4件: D00142 D00142, D00448 D00448, D02115 D02115, D08050 D08050 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
197 |
Metotrexato sandoz - 2.5 mg compresse 50 compresse in flacone pp |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
198 |
Mmf and dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
222 1件: 222 💬 |
199 |
Nabiximols |
Nabiximols |
1件: D09317 D09317 💬 |
- |
- |
013 1件: 13 💬 |
200 |
Nabiximols - sativex |
Nabiximols |
1件: D09317 D09317 💬 |
- |
- |
013 1件: 13 💬 |
201 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
2件: D02147 D02147, D02212 D02212 💬 |
ADRB2 6件: ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes 17件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
202 |
Normal saline |
- |
- |
- |
- |
006 16件: 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
203 |
Normal saline 0.9% infusion solution |
- |
- |
- |
- |
022 1件: 22 💬 |
204 |
Normal saline enema |
- |
- |
- |
- |
097 1件: 97 💬 |
205 |
Normal saline for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
206 |
Normal saline instillation |
- |
- |
- |
- |
226 1件: 226 💬 |
207 |
Normal saline iv, salt tablets |
- |
- |
- |
- |
299 1件: 299 💬 |
208 |
Normal saline solution |
- |
- |
- |
- |
299 1件: 299 💬 |
209 |
Normal saline: |
- |
- |
- |
- |
299 1件: 299 💬 |
210 |
Nsaids and sulfasalazine |
Sulfasalazine |
1件: D00448 D00448 💬 |
- |
- |
271 1件: 271 💬 |
211 |
Octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 7件: 67, 75, 84, 85, 89, 193, 227 💬 |
212 |
Octreotide acetate |
Acetate |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
227 1件: 227 💬 |
213 |
Octreotide lar |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 2件: 67, 227 💬 |
214 |
Octreotide lar / sandostatin lar (lar=long acting release) |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 1件: 84 💬 |
215 |
Octreotide-lar |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 1件: 67 💬 |
216 |
One additional blood sample during a planned blood test |
- |
- |
- |
- |
266 1件: 266 💬 |
217 |
Opc-41061 (tolvaptan) |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
218 |
Oral cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
219 |
Oral erythromycin |
Erythromycin |
9件: D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
036 1件: 36 💬 |
220 |
Orfiril saft |
- |
- |
- |
- |
003 1件: 3 💬 |
221 |
Other: antigen (wheat base soy sauce) spray |
Wheat |
1件: D06902 D06902 💬 |
- |
- |
098 1件: 98 💬 |
222 |
Other: biological samples |
- |
- |
- |
- |
206 1件: 206 💬 |
223 |
Other: blood sample |
- |
- |
- |
- |
299 1件: 299 💬 |
224 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 1件: 162 💬 |
225 |
Other: blood samples |
- |
- |
- |
- |
093 1件: 93 💬 |
226 |
Other: blood sampling for laboratory developed test (ldt) analysis |
- |
- |
- |
- |
065 1件: 65 💬 |
227 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 1件: 51 💬 |
228 |
Other: collection of csf, blood, urine, saliva |
- |
- |
- |
- |
006 1件: 6 💬 |
229 |
Other: continuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 1件: 299 💬 |
230 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 1件: 97 💬 |
231 |
Other: discontinuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 1件: 299 💬 |
232 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
233 |
Other: inhalable hypertonic saline 7% |
- |
- |
- |
- |
299 1件: 299 💬 |
234 |
Other: inhalable hypertonic saline 7% + hyaluronan 0.1% |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
299 1件: 299 💬 |
235 |
Other: intrathecal saline injection |
- |
- |
- |
- |
013 1件: 13 💬 |
236 |
Other: iv saline infusion |
- |
- |
- |
- |
096 1件: 96 💬 |
237 |
Other: joint mobilizations (spine, sacroiliac, hip) |
- |
- |
- |
- |
070 1件: 70 💬 |
238 |
Other: normal saline |
- |
- |
- |
- |
013 4件: 13, 222, 226, 280 💬 |
239 |
Other: normal saline for injection |
- |
- |
- |
- |
084 1件: 84 💬 |
240 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
241 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
149 1件: 149 💬 |
242 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
243 |
Other: saline |
- |
- |
- |
- |
002 8件: 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
244 |
Other: saline as a nasal spray |
- |
- |
- |
- |
226 1件: 226 💬 |
245 |
Other: saline solution |
- |
- |
- |
- |
067 1件: 67 💬 |
246 |
Other: saline solution. |
- |
- |
- |
- |
067 1件: 67 💬 |
247 |
Other: sputum sample |
- |
- |
- |
- |
299 1件: 299 💬 |
248 |
Other: sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
231 1件: 231 💬 |
249 |
Other: sterile saline |
- |
- |
- |
- |
046 1件: 46 💬 |
250 |
Other: stool sample |
- |
- |
- |
- |
006 2件: 6 , 299 💬 |
251 |
Other: subconjunctival injection of saline |
- |
- |
- |
- |
090 1件: 90 💬 |
252 |
Other: vehicle (d5w or saline) |
- |
- |
- |
- |
066 1件: 66 💬 |
253 |
Oxycodone depot ”sandoz”, depot tablets |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
298 1件: 298 💬 |
254 |
Pd00377 na-salt |
- |
- |
- |
- |
085 1件: 85 💬 |
255 |
Pentasa 2g sachet prolonged release granules (95%) |
- |
- |
- |
- |
097 1件: 97 💬 |
256 |
Pentasa sachet |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
257 |
Pentasa sachet 1 g |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
258 |
Pentasa sachet 1 g prolonged release granules |
- |
- |
- |
- |
096 1件: 96 💬 |
259 |
Pentasa sachet 1g |
- |
- |
- |
- |
097 1件: 97 💬 |
260 |
Pentasa sachet 2 g |
- |
- |
- |
- |
097 1件: 97 💬 |
261 |
Peri-neural dexamethasone 1 mg |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
262 |
Phosphate sandoz |
Phosphate ion |
- |
- |
- |
078 1件: 78 💬 |
263 |
Phosphate-buffered saline |
Phosphate ion |
- |
- |
- |
049 1件: 49 💬 |
264 |
Physiological saline |
- |
- |
- |
- |
051 1件: 51 💬 |
265 |
Pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 3件: 6 , 53, 299 💬 |
266 |
Pilocarpine hydrochloride |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 1件: 53 💬 |
267 |
Pilocarpine nitrate 5% |
Nitrate |
4件: D00525 D00525, D02200 D02200, D02313 D02313, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 1件: 299 💬 |
268 |
Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj |
Amantadine |
2件: D00777 D00777, D07441 D07441 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 1件: 6 💬 |
269 |
Placebo (physiological saline) |
- |
- |
- |
- |
043 2件: 43, 45 💬 |
270 |
Pnu-215062 sodium salt |
- |
- |
- |
- |
013 1件: 13 💬 |
271 |
Pomalidomide and dexamethasone |
Dexamethasone |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D08976 D08976 💬 |
IL6 3件: IL6, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 1件: 28 💬 |
272 |
Procedure: 2 ml of whole blood sample will be collected on edta tube |
Edetic acid |
8件: D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 1件: 51 💬 |
273 |
Procedure: biofluid samplings |
- |
- |
- |
- |
006 1件: 6 💬 |
274 |
Procedure: blood sample |
- |
- |
- |
- |
065 1件: 65 💬 |
275 |
Procedure: blood sampling for determination of serum zn |
- |
- |
- |
- |
299 1件: 299 💬 |
276 |
Procedure: blood sampling from infant |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
277 |
Procedure: blood sampling from mother |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
278 |
Procedure: blood sampling from umbilical cord |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
279 |
Procedure: blood sampling, endoscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
280 |
Procedure: breast milk sampling |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
281 |
Procedure: endoscopic repair of myelomeningocele before 26 sa |
- |
- |
- |
- |
118 1件: 118 💬 |
282 |
Procedure: epidural steroid (dexamethasone) injection |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
283 |
Procedure: infusion of saline |
- |
- |
- |
- |
097 1件: 97 💬 |
284 |
Procedure: injection of salivary glands |
- |
- |
- |
- |
002 1件: 2 💬 |
285 |
Procedure: iv deployment of csvf in sterile normal saline iv solution |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
286 |
Procedure: minor salivary gland (labial) biopsy |
- |
- |
- |
- |
053 1件: 53 💬 |
287 |
Procedure: pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 1件: 53 💬 |
288 |
Procedure: saline injection |
- |
- |
- |
- |
113 1件: 113 💬 |
289 |
Procedure: skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 srt patients included. |
- |
- |
- |
- |
102 1件: 102 💬 |
290 |
Procedure: spleen sample |
- |
- |
- |
- |
061 1件: 61 💬 |
291 |
Procedure: stool samples |
- |
- |
- |
- |
097 1件: 97 💬 |
292 |
Procedure: tissue samplings |
- |
- |
- |
- |
006 1件: 6 💬 |
293 |
R-hgh liquid (saizen) |
- |
- |
- |
- |
078 1件: 78 💬 |
294 |
R-salbutamol |
Levosalbutamol |
2件: D02147 D02147, D08124 D08124 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
295 |
R-salbutamol sulphate |
Levosalbutamol |
2件: D02147 D02147, D08124 D08124 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
296 |
Rabbit atg, cyclosporine, levamisole |
Antithymocyte immunoglobulin (rabbit) |
3件: D00184 D00184, D00750 D00750, D08114 D08114 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
297 |
Reduced glutathione sodium salt |
Glutathione |
2件: D00014 D00014, D00031 D00031 💬 |
- |
- |
299 1件: 299 💬 |
298 |
Regn475/sar164877 |
- |
- |
- |
- |
298 1件: 298 💬 |
299 |
Rhudex 100 mg (127 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
300 |
Rhudex 25 mg (31.75 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
301 |
Rhudex 50 mg (63.5 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
302 |
Rhudex choline salt |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
303 |
Ropivacaine plus normal saline |
Ropivacaine |
2件: D04048 D04048, D08490 D08490 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 1件: 70 💬 |
304 |
S-adenosyl-methionine (same) capsules |
Ademetionine |
3件: D00019 D00019, D04983 D04983, D07128 D07128 💬 |
- |
- |
093 1件: 93 💬 |
305 |
Sa |
- |
- |
- |
- |
006 5件: 6 , 30, 60, 118, 298 💬 |
306 |
Sa-001 |
- |
- |
- |
- |
298 1件: 298 💬 |
307 |
Sa237 |
- |
- |
- |
- |
013 1件: 13 💬 |
308 |
Sabril |
- |
- |
- |
- |
145 1件: 145 💬 |
309 |
Sabril granules for oral use |
- |
- |
- |
- |
145 1件: 145 💬 |
310 |
Sabril sachets |
- |
- |
- |
- |
145 1件: 145 💬 |
311 |
Sabrilex |
- |
- |
- |
- |
145 1件: 145 💬 |
312 |
Sabril® |
- |
- |
- |
- |
145 1件: 145 💬 |
313 |
Saccharomyces |
- |
- |
- |
- |
051 1件: 51 💬 |
314 |
Saccharomyces boulardii oral tablet |
- |
- |
- |
- |
051 1件: 51 💬 |
315 |
Sacubitril |
Sacubitril |
1件: D10225 D10225 💬 |
MME 1件: MME 💬 |
Alzheimer disease 4件: Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system |
058 1件: 58 💬 |
316 |
Sacubitril valsartan |
Sacubitril |
2件: D00400 D00400, D10225 D10225 💬 |
AGTR1 2件: AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications 19件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
317 |
Sacubitril/valsartan |
Sacubitril |
2件: D00400 D00400, D10225 D10225 💬 |
AGTR1 2件: AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications 19件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
318 |
Saf-301 |
- |
- |
- |
- |
019 1件: 19 💬 |
319 |
Safety observation |
- |
- |
- |
- |
006 1件: 6 💬 |
320 |
Saffron supplementation |
- |
- |
- |
- |
301 1件: 301 💬 |
321 |
Safinamida |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
322 |
Safinamide |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
323 |
Safinamide (as add-on therapy) |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
324 |
Safinamide + levodopa |
Levodopa |
2件: D00059 D00059, D10158 D10158 💬 |
DRD1 6件: DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 |
Alcoholism 20件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
325 |
Safinamide metansolfonato |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
326 |
Safinamide metansolfonato (12 weeks) |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
327 |
Safinamide methanesulfonate |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
328 |
Safinamide methanesulfonate 100mg |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
329 |
Safinamide methanesulfonate 150mg |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
330 |
Safinamide methansulfonate |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
331 |
Safinamide, mao-b inhibitor |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
332 |
Safinimide 50-100 mg/day |
- |
- |
- |
- |
006 1件: 6 💬 |
333 |
Sage |
Sage |
- |
- |
- |
006 1件: 6 💬 |
334 |
Sage leaf |
Sage |
- |
- |
- |
006 1件: 6 💬 |
335 |
Sage-217 |
- |
- |
- |
- |
006 1件: 6 💬 |
336 |
Sage-718 |
- |
- |
- |
- |
006 2件: 6 , 8 💬 |
337 |
Sait101 |
- |
- |
- |
- |
046 1件: 46 💬 |
338 |
Sait101 (proposed rituximab biosimilar) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 1件: 46 💬 |
339 |
Sait101 (rituximab biosimilar) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 1件: 46 💬 |
340 |
Saizen |
- |
- |
- |
- |
078 1件: 78 💬 |
341 |
Saizen 8mg click.easy powder for solution for injection |
- |
- |
- |
- |
078 1件: 78 💬 |
342 |
Saizen 8mg click.easy power for solution for injection |
- |
- |
- |
- |
078 1件: 78 💬 |
343 |
Saizen® |
- |
- |
- |
- |
078 1件: 78 💬 |
344 |
Saizen® solution for injection (referred as saizen®) |
- |
- |
- |
- |
078 1件: 78 💬 |
345 |
Salazopyrin |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
346 |
Salazopyrin en |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
347 |
Salazopyrin en 500 mg enterotabletter |
- |
- |
- |
- |
046 1件: 46 💬 |
348 |
Salazopyrin en-tabs |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
349 |
Salazopyrine |
- |
- |
- |
- |
046 1件: 46 💬 |
350 |
Salazosulfapyridine |
Sulfasalazine |
1件: D00448 D00448 💬 |
- |
- |
046 1件: 46 💬 |
351 |
Salbutamol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 9件: 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
352 |
Salbutamol 4mg tablet |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
353 |
Salbutamol sulfate |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
111 1件: 111 💬 |
354 |
Salbutamol sulfate ph. eur. |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
355 |
Salbutamol wzf 4 mg |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
356 |
Salicylazosulfapyridine |
Sulfasalazine |
1件: D00448 D00448 💬 |
- |
- |
271 1件: 271 💬 |
357 |
Salicylic acid |
Salicylic acid |
1件: D00097 D00097 💬 |
- |
- |
097 1件: 97 💬 |
358 |
Saline |
- |
- |
- |
- |
006 10件: 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
359 |
Saline 0.9% inhalation solution |
- |
- |
- |
- |
299 1件: 299 💬 |
360 |
Saline 0.9% nacl |
- |
- |
- |
- |
235 1件: 235 💬 |
361 |
Saline intranasal delivery |
- |
- |
- |
- |
006 1件: 6 💬 |
362 |
Saline nasal mist |
- |
- |
- |
- |
127 1件: 127 💬 |
363 |
Saline solution |
- |
- |
- |
- |
002 4件: 2 , 34, 288, 299 💬 |
364 |
Saline solution for injection |
- |
- |
- |
- |
019 1件: 19 💬 |
365 |
Salmeterol |
Salmeterol |
2件: D00687 D00687, D05792 D05792 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
299 1件: 299 💬 |
366 |
Salmon |
Salmon, unspecified |
- |
- |
- |
096 3件: 96, 97, 225 💬 |
367 |
Salofalk |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
368 |
Salofalk 1000mg granu-stix |
- |
- |
- |
- |
097 1件: 97 💬 |
369 |
Salofalk 1000mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
370 |
Salofalk 3g gastro-resistant prolonged-release granules |
- |
- |
- |
- |
097 1件: 97 💬 |
371 |
Salofalk 4g/60ml klysma |
- |
- |
- |
- |
097 1件: 97 💬 |
372 |
Salofalk 500 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
373 |
Salofalk granu-stix 500 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
374 |
Salofalk® 1000mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
375 |
Salofalk® 500 mg gastro-resistant tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
376 |
Salofalk® 500 mg tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
377 |
Salofalk® 500mg |
- |
- |
- |
- |
097 1件: 97 💬 |
378 |
Salofalk® 500mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
379 |
Salsalate |
Salsalate |
1件: D00428 D00428 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
005 1件: 5 💬 |
380 |
Sam |
- |
- |
- |
- |
006 1件: 6 💬 |
381 |
Sam-e |
Ademetionine |
1件: D07128 D07128 💬 |
- |
- |
006 1件: 6 💬 |
382 |
Same |
Ademetionine |
1件: D07128 D07128 💬 |
- |
- |
093 1件: 93 💬 |
383 |
Samsca |
- |
- |
- |
- |
067 2件: 67, 72 💬 |
384 |
Samsca 15 mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
385 |
Samsca 30 mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
386 |
Samsca*10cpr 15mg |
- |
- |
- |
- |
072 1件: 72 💬 |
387 |
San-300 |
- |
- |
- |
- |
046 1件: 46 💬 |
388 |
Sandimmum |
- |
- |
- |
- |
097 1件: 97 💬 |
389 |
Sandimmun |
- |
- |
- |
- |
097 2件: 97, 226 💬 |
390 |
Sandimmun 50 mg/ml, infuusiokonsentraatti |
- |
- |
- |
- |
097 1件: 97 💬 |
391 |
Sandimmun neoral |
- |
- |
- |
- |
060 3件: 60, 97, 226 💬 |
392 |
Sandimmun neoral*30cps 100mg |
- |
- |
- |
- |
046 1件: 46 💬 |
393 |
Sandimmun neoral*50cps 25mg |
- |
- |
- |
- |
046 1件: 46 💬 |
394 |
Sandimmun optoral |
- |
- |
- |
- |
053 2件: 53, 113 💬 |
395 |
Sandinum |
- |
- |
- |
- |
097 1件: 97 💬 |
396 |
Sandostatin lar |
- |
- |
- |
- |
067 4件: 67, 84, 193, 227 💬 |
397 |
Sandostatin lar 20 mg |
- |
- |
- |
- |
227 1件: 227 💬 |
398 |
Sandostatina |
- |
- |
- |
- |
067 1件: 67 💬 |
399 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 1件: 67 💬 |
400 |
Sandostatina lar |
- |
- |
- |
- |
067 1件: 67 💬 |
401 |
Sandostatina lar im fl 20mg +2f |
- |
- |
- |
- |
067 1件: 67 💬 |
402 |
Sandostatine |
- |
- |
- |
- |
096 1件: 96 💬 |
403 |
Sapropterin |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
086 3件: 86, 124, 240 💬 |
404 |
Sapropterin (kuvan) |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
405 |
Sapropterin dihydrochloride |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
406 |
Sapropterin dihydrochloride (6r-bh4) |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
086 1件: 86 💬 |
407 |
Sapropterin dihydrochloride, 6r-bh4, tetrahydrobiopterin |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
408 |
Sapropterin dihydrocholoride |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
409 |
Sapropterin hydrochloride |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
410 |
Sapropterin, sapropterin dihydrochloride |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
411 |
Sapropterin, sapropterin hydrochloride |
Sapropterin |
1件: D08505 D08505 💬 |
- |
- |
240 1件: 240 💬 |
412 |
Sapropterindihydrochloride |
- |
- |
- |
- |
240 1件: 240 💬 |
413 |
Saproterin dihydrochloride |
- |
- |
- |
- |
240 1件: 240 💬 |
414 |
Saquinavir |
Saquinavir |
2件: D00429 D00429, D01160 D01160 💬 |
- |
- |
086 2件: 86, 265 💬 |
415 |
Saquinavir and ritonavir |
Ritonavir |
3件: D00427 D00427, D00429 D00429, D01160 D01160 💬 |
- |
- |
086 1件: 86 💬 |
416 |
Sar |
- |
- |
- |
- |
046 1件: 46 💬 |
417 |
Sar100842 |
- |
- |
- |
- |
051 1件: 51 💬 |
418 |
Sar113244 |
- |
- |
- |
- |
049 1件: 49 💬 |
419 |
Sar153191 |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 4件: 41, 46, 107, 271 💬 |
420 |
Sar153191 (regn88) |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 2件: 46, 107 💬 |
421 |
Sar156597 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
422 |
Sar156597 (act14604) |
- |
- |
- |
- |
051 1件: 51 💬 |
423 |
Sar231893 |
- |
- |
- |
- |
051 2件: 51, 160 💬 |
424 |
Sar236553 |
- |
- |
- |
- |
079 1件: 79 💬 |
425 |
Sar339658 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
426 |
Sar402671, gz402671 or gz/sar402671 |
- |
- |
- |
- |
006 3件: 6 , 19, 67 💬 |
427 |
Sar421869 |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
428 |
Sar422459 |
- |
- |
- |
- |
301 1件: 301 💬 |
429 |
Sar441344 |
- |
- |
- |
- |
053 1件: 53 💬 |
430 |
Sar442168 |
- |
- |
- |
- |
013 1件: 13 💬 |
431 |
Saracatinab |
- |
- |
- |
- |
085 1件: 85 💬 |
432 |
Saracatinib |
Saracatinib |
1件: D09664 D09664 💬 |
ABL1 2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
006 3件: 6 , 89, 272 💬 |
433 |
Saracatinib difumarate |
Saracatinib |
1件: D09664 D09664 💬 |
ABL1 2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
272 1件: 272 💬 |
434 |
Sarcosine |
Sarcosine |
- |
- |
- |
006 1件: 6 💬 |
435 |
Sarcosine capsule |
Sarcosine |
- |
- |
- |
006 1件: 6 💬 |
436 |
Sargramostim |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 7件: 6 , 28, 60, 62, 96, 229, 285 💬 |
437 |
Sargramostim (leukine) |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
096 1件: 96 💬 |
438 |
Sarilumab |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 5件: 41, 46, 84, 107, 271 💬 |
439 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara] |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
440 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]_#1 |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
084 1件: 84 💬 |
441 |
Sarilumab sar153191 |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 1件: 41 💬 |
442 |
Sarilumab sar153191 (regn88) |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 2件: 46, 107 💬 |
443 |
Sarizotan |
Sarizotan |
- |
- |
- |
006 2件: 6 , 156 💬 |
444 |
Sarizotan hc1 |
Sarizotan |
- |
- |
- |
006 1件: 6 💬 |
445 |
Sarizotan hcl |
Sarizotan |
- |
- |
- |
006 1件: 6 💬 |
446 |
Sarizotan hydrochloride |
Sarizotan |
- |
- |
- |
006 2件: 6 , 156 💬 |
447 |
Saroglitazar |
Saroglitazar |
- |
- |
- |
093 1件: 93 💬 |
448 |
Saroglitazar magnesium 2 mg |
Magnesium |
- |
- |
- |
093 1件: 93 💬 |
449 |
Saroglitazar magnesium 4 mg |
Magnesium |
- |
- |
- |
093 1件: 93 💬 |
450 |
Satavaptan |
Satavaptan |
- |
- |
- |
072 1件: 72 💬 |
451 |
Satavaptan (sr121463) |
Satavaptan |
- |
- |
- |
072 1件: 72 💬 |
452 |
Satavaptan (sr121463b) |
Satavaptan |
- |
- |
- |
072 1件: 72 💬 |
453 |
Sativex |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
454 |
Sativex oromucosal spray |
- |
- |
- |
- |
013 1件: 13 💬 |
455 |
Sativex oromucosal spray (non-marketed) |
- |
- |
- |
- |
013 1件: 13 💬 |
456 |
Sativex® |
- |
- |
- |
- |
013 1件: 13 💬 |
457 |
Satralizumab |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
458 |
Satralizumab (120 mg/pfs with nsd) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
459 |
Satralizumab (120 mg/vial) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
460 |
Satralizumab (120mg/vial) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
461 |
Satralizumab (r-inn) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
462 |
Satralizumab (ro5333787/enspryng /sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
463 |
Satralizumab (ro5333787/enspryng/sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
464 |
Satralizumab (ro5333787/sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
465 |
Satrazlizumab (ro5333787/ enspryng /sa237) |
- |
- |
- |
- |
013 1件: 13 💬 |
466 |
Sauerstoff |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
467 |
Saxagliptin |
Saxagliptin |
1件: D08996 D08996 💬 |
DPP4 1件: DPP4 💬 |
Protein digestion and absorption 1件: Protein digestion and absorption |
299 1件: 299 💬 |
468 |
Saxenda |
- |
- |
- |
- |
193 1件: 193 💬 |
469 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
7件: D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D02691 D02691, D07448 D07448, D08623 D08623 💬 |
GHR 4件: GHR, OPRM1, SLC6A2, SLC6A4 💬 |
Cytokine-cytokine receptor interaction 9件: Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle |
078 1件: 78 💬 |
470 |
Sc treatment with igsc, 10% with rhuph20 followed by iv/igsc, 10% only (safety) |
- |
- |
- |
- |
065 1件: 65 💬 |
471 |
Sc treatment with igsc, 10% with rhuph20 followed by sc/igsc, 10% only (safety) |
- |
- |
- |
- |
065 1件: 65 💬 |
472 |
Silikis 3µg/g salbe |
- |
- |
- |
- |
037 1件: 37 💬 |
473 |
Simvastatina sandoz 40 mg comprimidos recubiertos con película efg |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
474 |
Simvastatine sandoz 40 mg filmomhulde tabletten |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
475 |
Simvastatine sandoz 40mg deelbare filmomhulde tabletten |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
476 |
Sinvastatina sandoz 40 mg comprimidos revestidos por película |
- |
- |
- |
- |
013 1件: 13 💬 |
477 |
Sodium acid pyrophosphate sapp ror 28 food grade |
- |
- |
- |
- |
166 1件: 166 💬 |
478 |
Stavudine |
Stavudine |
1件: D00445 D00445 💬 |
- |
- |
265 1件: 265 💬 |
479 |
Sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
062 3件: 62, 234, 254 💬 |
480 |
Sterile normal saline for intravenous use |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
481 |
Sterile saline |
- |
- |
- |
- |
227 1件: 227 💬 |
482 |
Sterile saline for injection |
- |
- |
- |
- |
097 1件: 97 💬 |
483 |
Sterile saline solution |
- |
- |
- |
- |
051 1件: 51 💬 |
484 |
Strontium ranelate |
Strontium ranelate |
1件: D08468 D08468 💬 |
- |
- |
078 1件: 78 💬 |
485 |
Sulfasalazine |
Sulfasalazine |
1件: D00448 D00448 💬 |
- |
- |
046 4件: 46, 86, 94, 271 💬 |
486 |
Sulfasalazine, ssz |
Sulfasalazine |
1件: D00448 D00448 💬 |
- |
- |
271 1件: 271 💬 |
487 |
Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt) |
Hydrogen |
- |
- |
- |
006 1件: 6 💬 |
488 |
Teicoplanin sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. |
Teicoplanin |
1件: D02142 D02142 💬 |
- |
- |
299 1件: 299 💬 |
489 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 1件: 86 💬 |
490 |
Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs) |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
491 |
Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs) |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
051 1件: 51 💬 |
492 |
Tolvaptan |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 3件: 67, 72, 225 💬 |
493 |
Tolvaptan (opc-41061) |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
494 |
Tolvaptan 15 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
495 |
Tolvaptan 15 mg tablet |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
496 |
Tolvaptan 15 mg tablets |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
497 |
Tolvaptan 15mg |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
498 |
Tolvaptan 30 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
499 |
Tolvaptan 30 mg tablet |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
500 |
Tolvaptan 30 mg tablets |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
501 |
Tolvaptan 30mg |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
502 |
Tolvaptan 45/15 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
503 |
Tolvaptan 60/30 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
504 |
Tolvaptan 7.5 mg tablet |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
505 |
Tolvaptan in euvolemic hyponatremia |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 1件: 72 💬 |
506 |
Tolvaptan ir |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
507 |
Tolvaptan mr |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
508 |
Tolvaptan oral tablet |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 1件: 72 💬 |
509 |
Trexan+salazopyrin+oxiklorin+prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
510 |
Trexan+salazopyrin+oxiklorin+prednisolone + infliximab |
Infliximab |
9件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02598 D02598, D03301 D03301 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
511 |
Triamcinolone acetonide and normal saline solution |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
512 |
Twice-daily dosage with 0.5% cyclosporine-a eyedrops |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
513 |
Uk: sativex oromucosal spray |
- |
- |
- |
- |
013 1件: 13 💬 |
514 |
Urine sample |
- |
- |
- |
- |
049 3件: 49, 51, 61 💬 |
515 |
Urine samples |
- |
- |
- |
- |
013 1件: 13 💬 |
516 |
Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
517 |
Ushstat (sar421869) |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
518 |
Venglustat (gz/sar402671) |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
519 |
Venglustat gz/sar402671 |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
067 1件: 67 💬 |
520 |
Venous blood sample |
- |
- |
- |
- |
046 1件: 46 💬 |
521 |
Vigabatrin |
Vigabatrin |
1件: D00535 D00535 💬 |
ABAT 1件: ABAT 💬 |
Alanine, aspartate and glutamate metabolism 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 2件: 145, 158 💬 |
522 |
Vigabatrin (sabril) |
Vigabatrin |
1件: D00535 D00535 💬 |
ABAT 1件: ABAT 💬 |
Alanine, aspartate and glutamate metabolism 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
158 1件: 158 💬 |
523 |
Vigabatrin tablets |
Vigabatrin |
1件: D00535 D00535 💬 |
ABAT 1件: ABAT 💬 |
Alanine, aspartate and glutamate metabolism 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 1件: 145 💬 |
524 |
Vigabatrin: vigabatrin new st formulation then sabril® |
Vigabatrin |
1件: D00535 D00535 💬 |
ABAT 1件: ABAT 💬 |
Alanine, aspartate and glutamate metabolism 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 1件: 145 💬 |
525 |
Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1 |
Choline |
1件: D07690 D07690 💬 |
- |
- |
299 1件: 299 💬 |
526 |
Vx-371 in hypertonic saline |
- |
- |
- |
- |
299 1件: 299 💬 |
527 |
Vx-371 in saline |
- |
- |
- |
- |
299 1件: 299 💬 |
528 |
Whole blood sample |
- |
- |
- |
- |
177 1件: 177 💬 |
529 |
Xadago (safinamide) |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
530 |
Zolpidem |
Zolpidem |
2件: D00706 D00706, D08690 D08690 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
005 3件: 5 , 6 , 46 💬 |
531 |
Zolpidem first dose |
Zolpidem |
2件: D00706 D00706, D08690 D08690 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 1件: 6 💬 |
532 |
Zolpidem second dose |
Zolpidem |
2件: D00706 D00706, D08690 D08690 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 1件: 6 💬 |
533 |
Zolpidem tartrate |
Zolpidem |
2件: D00706 D00706, D08690 D08690 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 1件: 6 💬 |
534 |
lnp023 hydrochloride salt |
- |
- |
- |
- |
062 3件: 62, 66, 222 💬 |